This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Hereditary Sideroblastic Anemia
Information about Hereditary Sideroblastic Anemia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Hereditary Sideroblastic Anemia
Most recent studies have shown that Hereditary Sideroblastic Anemia shares some biological mechanisms with anemia, ataxia, beta-thalassemia, dysmyelopoietic-syndromes, erythropoietic-protoporphyria, friedreich-ataxia, genetic-diseases-x-linked, hemochromatosis, hypochromic-anemia, iron-deficiency, iron-deficiency-anemia, iron-overload, microcytic-anemia, microcytic-hypochromic-anemia-(disorder), pyridoxine-responsive-sideroblastic-anemia, refractory-anemia-with-ringed-sideroblasts, refractory-anemias, secondary-acquired-sideroblastic-anemia, sideroblastic-anemia, thalassemia.
Among the many pathways, these few ones have gauged particular interests from scientists studying Hereditary Sideroblastic Anemia, and have been seen in publications frequently: Cell Death, Cell Differentiation, Cell Proliferation, Erythrocyte Development, Excretion, Gene Silencing, Heme Transport, Hemopoiesis, Hypersensitivity, Interferon-alpha Production, Iron-sulfur Cluster Assembly, Localization, Methylation, Oxidative Phosphorylation, Oxygen Transport, Pathogenesis, Protein Maturation, Regulation Of Gene Expression, Translation, Transport
Quite a number of genes have been found to play important roles in Hereditary Sideroblastic Anemia, such as ABCB6, ABCB7, ALAS1, ALAS2, EPO, FECH, FTMT, FXN, GLRX5, HAMP, HFE, OXA1L, PDXP, PLP1, PRDX5, PTHLH, SLC25A38, TF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.